Clicky

Working for Cuomo a ‘dark moment in my life’ leading to depression, anxiety

NEW YORK (PIX11) — Not only is Sen. Alessandra Biaggi among the dozens of New York lawmakers calling on Gov. Andrew Cuomo to resign amid multiple harassment allegations, but she also briefly worked in his administration. She called it “a very dark moment in my life.” More coverage || Cuomo under fire Biaggi is among more

Working for Cuomo a ‘dark moment in my life’ leading to depression, anxiety Read More »

Melissa & Doug co-founder reveals battle with ‘existential anxiety and depression’

Melissa & Doug co-founder Melissa Bernstein is sharing her battle with “existential anxiety and depression.” (Photo: Courtesy of Melissa Bernstein) As co-founder of the popular toy company Melissa & Doug, everything Melissa Bernstein touched — from peg puzzles to pretend play kitchens — teemed with a Technicolor levity. But, as her achingly honest new memoir

Melissa & Doug co-founder reveals battle with ‘existential anxiety and depression’ Read More »

China February exports post record surge from COVID-19-depressed 2020 levels

BEIJING (Reuters) – China’s February exports grew at a record pace from a year earlier when COVID-19 battered the world’s second-biggest economy, customs data showed on Sunday, while imports rose less sharply. FILE PHOTO: Cranes and containers are seen at the Yantian port in Shenzhen, following the novel coronavirus disease (COVID-19) outbreak, Guangdong province, China

China February exports post record surge from COVID-19-depressed 2020 levels Read More »

World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor Canadian Stock Exchange:PHRM.CN

TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Newscope Capital Corporation (the “Company” or “Newscope”) (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce the appointment of Dr. Maurizio Fava, MD, as a scientific

World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor Canadian Stock Exchange:PHRM.CN Read More »

Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders

NEW YORK and TOKYO, March 16, 2021 /PRNewswire/ — Perception Neuroscience (Perception), an atai Life Sciences (atai) company focused on developing innovative therapies in neuropsychiatric disorders, and Otsuka Pharmaceutical Co., Ltd. (Otsuka), announce a collaboration and licensing agreement for the development and commercialization of Perception’s lead molecule, PCN-101 (R-ketamine) in Japan as a potential treatment

Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders Read More »

Major Depressive Disorder (MDD) Treatment Market Comprehensive Research Study 2020 | Size, Share, Trend, Growth, Global Demand, Future Strategic Planning & Demand by 2026

Global Major Depressive Disorder (MDD) Treatment Market Major depressive disorder (MDD), also known as clinical depression, is a mental health disorder which affects mood, behavior, as well as appetite and sleep. The exact cause of MDD is not known; however, several factors that can potentially increase its risk include a combination of genes and stress

Major Depressive Disorder (MDD) Treatment Market Comprehensive Research Study 2020 | Size, Share, Trend, Growth, Global Demand, Future Strategic Planning & Demand by 2026 Read More »